Breaking News

Charles River Acquires Blue Stream Labs

Offers clients an integrated portfolio for biologic and biosimilar drug development

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles River Laboratories has acquired Blue Stream Laboratories. Combining Blue Stream with Charles River’s existing discovery, safety assessment, and biologics capabilities creates a leading provider with the ability to support biologic and biosimilar development from characterization through clinical testing and commercialization. Blue Stream is an analytical contract research organization (CRO) supporting the development of complex biologics and biosimilars. Located in Woburn, MA, the com...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters